1. Home
  2. NYAX vs EVO Comparison

NYAX vs EVO Comparison

Compare NYAX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYAX
  • EVO
  • Stock Information
  • Founded
  • NYAX 2005
  • EVO 1993
  • Country
  • NYAX Israel
  • EVO Germany
  • Employees
  • NYAX N/A
  • EVO N/A
  • Industry
  • NYAX
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NYAX
  • EVO Health Care
  • Exchange
  • NYAX Nasdaq
  • EVO Nasdaq
  • Market Cap
  • NYAX 1.8B
  • EVO 1.4B
  • IPO Year
  • NYAX N/A
  • EVO 2021
  • Fundamental
  • Price
  • NYAX $45.26
  • EVO $3.88
  • Analyst Decision
  • NYAX Buy
  • EVO Strong Buy
  • Analyst Count
  • NYAX 6
  • EVO 1
  • Target Price
  • NYAX $42.00
  • EVO $7.00
  • AVG Volume (30 Days)
  • NYAX 7.3K
  • EVO 45.0K
  • Earning Date
  • NYAX 11-11-2025
  • EVO 11-05-2025
  • Dividend Yield
  • NYAX N/A
  • EVO N/A
  • EPS Growth
  • NYAX N/A
  • EVO N/A
  • EPS
  • NYAX 0.57
  • EVO N/A
  • Revenue
  • NYAX $348,663,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • NYAX $31.84
  • EVO N/A
  • Revenue Next Year
  • NYAX $22.85
  • EVO $10.78
  • P/E Ratio
  • NYAX $79.37
  • EVO N/A
  • Revenue Growth
  • NYAX 29.63
  • EVO N/A
  • 52 Week Low
  • NYAX $25.32
  • EVO $2.84
  • 52 Week High
  • NYAX $52.46
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • NYAX 37.62
  • EVO 52.60
  • Support Level
  • NYAX $46.12
  • EVO $3.85
  • Resistance Level
  • NYAX $46.86
  • EVO $4.04
  • Average True Range (ATR)
  • NYAX 0.83
  • EVO 0.08
  • MACD
  • NYAX -0.32
  • EVO -0.00
  • Stochastic Oscillator
  • NYAX 14.70
  • EVO 28.00

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: